Dr Martens
Dr. Martens plc is a UK heritage footwear brand (founded 1960, LSE: DOCS) designing and selling iconic boots, shoes, and accessories across 60+ countries through DTC stores/e-commerce and global wholesale, serving mainstream consumers with subcultural style appeal and growing sustainability credentials.
- Company typePublic
- Founded1960
- HeadquartersWollaston, United Kingdom
- Headcount1,001–5,000
- GTM typeB2C
- OfferingHardware or Manufacturing
What Dr Martens does
Dr. Martens plc is a UK-founded (1960) heritage footwear brand listed on the London Stock Exchange under ticker DOCS, operating in over 60 countries with 3,650+ employees. The company designs, manufactures, and distributes boots, shoes, sandals, and accessories anchored by iconic silhouettes — the 1460 eight-eye lace-up boot, 1461 Oxford shoe, and 2976 Chelsea boot — built on proprietary Goodyear welted construction and the signature air-cushioned 'Buzz' sole. The product portfolio extends into Vegan, Made in England (handcrafted in Wollaston), platform boots (Jadon, Sinclair), kids' footwear, loafers, Mary Janes, mules, sandals, and accessories including bags and shoe care, supplemented by limited-edition collaborations with brands such as Supreme, Metallica, Marc Jacobs, Beams, and Netflix's Wednesday.
The business operates a hybrid go-to-market model combining direct-to-consumer (40+ country-specific e-commerce sites and owned retail stores) with wholesale distribution to department stores, specialty footwear retailers, and multi-brand fashion partners globally. Revenue is generated through unit pricing on core products (€130–€280 / $130–$340 range depending on style and market), augmented by seasonal promotions (up to 30% off), a 10% student discount, Klarna BNPL in multiple markets, and a brand-owned resale platform (ReWair) launched in the US in March 2024. Sustainability initiatives include a four-season partnership with Gen Phoenix for reclaimed leather (Genix Nappa / Solar Flare collection), with 15 tonnes of leather offcuts diverted from waste and 693 tCO2e saved to date.
In FY26 (year ended 29 March 2026), Dr. Martens reported revenue of £764.9m (down 1.4% YoY) and adjusted pre-tax profit of £55.0m (up 61% YoY) under a new consumer-first strategy that intentionally reduced clearance and off-price DTC activity in favor of full-price sales and wholesale channel growth. The company is currently executing a leadership restructuring with regional General Managers across UK, France, DACH, and Italy, and has invested in digital infrastructure via a new Global Capability Centre in Bengaluru and a consolidated London headquarters at 20 Whitfield Street.
Dr Martens firmographics
Firmographics- Name
- Dr Martens
- Legal name
- Airwair International Ltd.
- Website
- https://drmartens.com
- Company type
- Public
- Founded year
- 1960
- Operating status
- Operating
- Headcount range
- 1,001–5,000 employees
- Short description
- Dr. Martens plc is a UK heritage footwear brand (founded 1960, LSE: DOCS) designing and selling iconic boots, shoes, and accessories across 60+ countries through DTC stores/e-commerce and global wholesale, serving mainstream consumers with subcultural style appeal and growing sustainability credentials.
- Ownership category
- akta.pro rank
Dr Martens industry classification
Industry- Product category
- Heritage Footwear
- NAICS
- Footwear Manufacturing (3162), Shoe Retailers (45821)
- SIC
- Footwear, (No Rubber) (3140), Retail-Shoe Stores (5661)
- akta.pro primary industry
- Casual & Lifestyle Footwear (CRAAACAB)
- akta.pro secondary industries
- Sustainable & Eco-Friendly Footwear (CRAAACAH), Footwear Components & Materials (Uppers, Soles, Laces, Insoles) (CRAAACAK), Apparel, Footwear & Accessories Resale (CRAFAGAA)
Keywords
Where Dr Martens is headquartered
LocationHeadquarters
- HQ city
- Wollaston
- HQ country
- United Kingdom
- HQ region
- Europe
Offices2 records
Markets served
Dr Martens business model
Business model- GTM type
- B2C
- Offering type
- Hardware or Manufacturing
- Cost components
- Supply Chain, Operations, Marketing or Sales, Personnel, Technology or R&D, Infrastructure
Revenue model
- Direct-to-Consumer (DTC): Revenue from owned retail stores and e-commerce websites serving global markets. DTC revenue fell 6.5% in Q3 FY26 as the company deliberately reduced clearance and off-price activity to improve revenue quality, though gross margin expanded 120 basis points to 66.2% as a result.
- Wholesale: Revenue from third-party retail partners and distributors. Wholesale grew 9.5% in Q3 FY26 as the company shifted volume away from DTC clearance toward wholesale channels, with strong order books supporting FY27 profit growth.
- Brand-Owned Resale (ReWair): Dr. Martens launched the ReWair resale platform in the US in March 2024, selling over 10,000 pre-loved pairs and attracting new customers to the brand. The company is considering expanding ReWair internationally to capitalize on the growing second-hand market.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Unit Pricing | Pay-as-you-go | Full-price retail across all product categories |
| Other | Pay-as-you-go | Student discount program |
| Other | Pay-as-you-go | Buy Now, Pay Later (Klarna) |
Go-to-market motion3 records
Distribution channels5 records
Marketing channels9 records
Dr Martens product offering
Product offeringCore offering
Dr. Martens designs, manufactures, and sells iconic heritage footwear including the 1460 boot, 1461 shoe, 2976 Chelsea boot, and platform styles (Jadon, Sinclair), along with sandals, loafers, Mary Janes, kids' footwear, bags, and accessories. The company sells through owned retail stores in major markets, 40+ country-specific e-commerce websites, and wholesale distribution to third-party retailers, complemented by the ReWair brand-owned resale platform for pre-loved products.
Product overview
Dr Martens is a heritage footwear brand offering a diverse product portfolio centered around its iconic boot and shoe designs. The core offerings include the 1460 (8-eye lace-up boot), 1461 (3-eye Oxford shoe), and 2976 (Chelsea boot) as part of the Originals collection. The brand extends its portfolio through sub-brands including the Vegan collection (animal-free products), Made in England line (handcrafted at the original factory), and various platform boot styles (Jadon, Sinclair). Beyond footwear, the product range encompasses sandals, mules, loafers, Mary Jane shoes, and accessories such as bags, shoe care products, socks, and laces. Kids footwear covers sizes from baby to youth. The company also operates the ReWair resale platform for pre-loved products and has partnerships for sustainable materials including Gen Phoenix recycled leather.
Differentiator
Problem solved
Functional benefit
Brands
- ReWair: Brand-owned resale platform for second-hand Dr. Martens boots, launched in the US in March 2024, with over 10,000 pairs sold and plans for international expansion
Products and services
- 1460 Boot The iconic 8-eye lace-up boot, the original Dr. Martens boot featuring the distinctive yellow stitching and AirWair sole, priced from approximately €200 / £170 / $160–$200.
- 1461 Shoe The 3-eye Oxford shoe, a classic design that complements the 1460 boot as part of the Originals collection, priced from approximately €185 / £150 / $150–$180.
- 2976 Chelsea Boot The elastic-sided Chelsea boot version of the classic Dr. Martens design with the signature yellow stitching.
- Jadon Platform Boot Platform boot featuring the signature DMS sole with enhanced height and bold silhouette.
- Sinclair Platform Boot Women's platform boot collection featuring various leather treatments including Flower and Grizzly styles.
- Vegan Collection Footwear and accessories made without animal products, including vegan boots, shoes, and bags, appealing to vegan and sustainability-conscious consumers.
- Made in England Products handcrafted at the original factory in Wollaston, Northamptonshire, where Dr. Martens began in 1960, representing premium craft heritage.
- Kids Footwear Footwear for children including boots, shoes, and sandals in sizes for babies, toddlers, juniors, and youth.
- Accessories Including leather bags, backpacks, heart bags, mini bags, socks, shoe care products, laces, and insoles.
- Mary Jane Shoes Classic Mary Jane styles including the 8065 and newer Flower variations for women, priced from approximately €130–€195 / $130–$210.
- Loafers Men's and women's loafers including Tassel Loafers, Penny Loafers, and casual styles such as the Adrian.
- Sandals Summer footwear including gladiator sandals, slides, platform sandals, and lightweight styles.
- Mules Backless shoes and clogs featuring DMS sole technology.
- ReWair Resale Platform Brand-owned resale platform allowing customers to buy authenticated pre-loved Dr. Martens products, extending product lifecycle and promoting sustainability.
- Dr. Martens x Metallica Limited-Edition Collection Limited-edition collaboration collection featuring the 1460 boot ($200) and 1461 shoe ($180) with Metallica tour graphics by Pushead and black-on-black styling.
- Dr. Martens x Wednesday Collaboration Footwear and apparel collaboration with the Netflix show Wednesday, including nine pieces of boots and backpack priced from $130 to $210, capitalizing on the show's popularity and Halloween season.
- Solar Flare Collection (Gen Phoenix Partnership) Sustainable collection made from Genix Nappa reclaimed leather in partnership with Gen Phoenix, spanning boots, kids' footwear, and bags.
- Supreme x Dr. Martens Limited-Edition Shoe Collaboration Limited-edition streetwear shoe collaboration between Supreme and Dr. Martens, leveraging Supreme's cult following and Dr. Martens' heritage boot audience.
- Floral Deboss Spring Collection Spring collection featuring premium leather pieces in deep brown hues with debossed floral details and antique hardware, including the $150 Mary Jane shoe, $170 1460 boot, and $210 Sinclair Flower platform boot.
Quantifiable outcome
- Gross margin expanded 120 basis points to 66.2% in FY26 by reducing clearance and off-price activity
- +4 more outcomes
Companies that use Dr Martens
Customer profileNamed customers1 record
Segments4 records
Ideal customer profiles4 records
Dr Martens technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature4 records
Dr Martens partnerships and signals
Strategic signalPartnerships
Eight partnerships are on record, tiered core, flagship and minor.
- Brand-Owned Resale Program (ReWair)coreDr. Martens operates ReWair, a brand-owned resale platform launched in the US in March 2024. The platform has sold over 10,000 pre-loved pairs of Dr. Martens boots, extending product lifecycles and attracting new customers to the brand. The company is considering expanding the platform internationally to capitalize on the booming second-hand economy, which is projected to reach $320-360 billion by 2030.
- SupremeflagshipSupreme and Dr. Martens launched a brand-new limited-edition shoe collaboration, continuing the streetwear brand's tradition of high-profile footwear partnerships. The collaboration targets Supreme's cult following and Dr. Martens' heritage boot audience, creating buzz through scarcity and cultural crossover between the two brands.
- BeamsminorDr. Martens collaborated with Japanese retailer and brand Beams on a footwear collection released in early 2026, as part of a broader surge in fashion brand collaborations spanning streetwear, luxury, and heritage labels.
- Marc JacobsflagshipDr. Martens collaborated with designer Marc Jacobs on the Kiki boot, part of a series of collaborations by Marc Jacobs with heritage footwear brands. The collaboration was cited alongside the Metallica partnership as additional product news from the brand during the spring 2026 season.
- MetallicaflagshipDr. Martens unveiled its first creative partnership with heavy metal band Metallica, launching a limited-edition footwear collection featuring the iconic 1460 boot and 1461 shoe. The collection incorporates graphics from Metallica's 1988 Damage Justice and 1986 Damage Inc. tours by artist Pushead, along with a black-on-black edition referencing the 1991 self-titled album. The collaboration leverages both brands' shared association with grunge and counterculture aesthetics, priced at $200 for the 1460 boot and $180 for the 1461 shoe.
- Gen PhoenixcoreDr. Martens entered a long-term materials partnership with Gen Phoenix to incorporate recycled leather into its products. The partnership, spanning four consecutive seasons, produces the Genix Nappa reclaimed leather line and Solar Flare collection. To date, the partnership has diverted 15 tonnes of leather offcuts from waste and saved an estimated 693 tCO₂e. The collaboration expanded into kids' footwear and bags, demonstrating the scalability of Gen Phoenix's circular technology platform. Both brands target net-zero emissions by 2040.
- Wednesday (Netflix)flagshipDr. Martens launched a footwear and apparel collaboration with the Netflix show Wednesday, celebrating the show's successful second season. The collection includes nine pieces including updated boot styles and a backpack, priced from $130 to $210. The collaboration capitalizes on the show's popularity, particularly around the Halloween season, and targets the show's young, fashion-forward fanbase.
- Fashion for GoodcoreDr. Martens joined 'Closing the Footwear Loop,' an initiative by Fashion for Good bringing together 14-15 fashion and footwear brands to transform the industry's linear take-make-dispose model into a circular one. The project maps European footwear waste streams, develops circular design roadmaps, and validates end-of-use recycling innovations. The initiative addresses the crisis where approximately 90% of 23.8 billion shoes produced annually end up in landfills.
Scale indicators12 records
Recent moves7 records
Expansion highlights5 records
Dr Martens competitors and assessment
Company assessmentDirect peers
- Crocs: Public footwear company (NASDAQ: CROX) with a comparable single-iconic-silhouette (Classic Clog) business model, broad global distribution, celebrity collaborations, and a recent track record of margin expansion through full-price discipline. Highly relevant peer for understanding brand-monetization dynamics.
- Clarks: Long-standing UK heritage footwear brand with iconic silhouettes (e.g., Wallabee, Desert Boot) and a comparable consumer base of mainstream, family-oriented and fashion-conscious shoppers. Similar premium-casual positioning, multi-channel DTC + wholesale distribution, and recent focus on repositioning for premium pricing.
- Steve Madden: US-based fashion footwear company (NASDAQ: SHOO) with a similar hybrid DTC + wholesale model, fashion-forward product cadence, and a comparable reliance on trend-led silhouettes. Differs in being more trend-cycle-driven vs. Dr. Martens' heritage-anchored positioning.
- Hunter Boot: Heritage British footwear brand known for the iconic Original Tall Wellington boot. Comparable heritage positioning, multi-channel distribution, and exposure to UK/EU consumer trends, though smaller scale and currently privately held.
- Birkenstock: German heritage footwear brand recently IPO'd (NYSE: BIRK) with comparable iconic-silhouette strategy (Arizona, Boston), premium pricing, growing DTC mix, and broad demographic appeal. A direct comparable for Dr. Martens on heritage brand economics, full-price discipline, and consumer-first narrative.
- Blundstone: Australian heritage boot brand best known for its iconic Chelsea boot (585 series). Directly comparable on heritage-boot positioning, durable construction, and global DTC + wholesale distribution, with a smaller but loyal customer base.
- Timberland: Heritage boot brand owned by VF Corporation with comparable icon-silhouette strategy (6-inch boot), similar workwear-to-fashion crossover positioning, and broad global wholesale + DTC distribution. Closely competes with Dr. Martens in the heritage casual boot category.
- UGG (Deckers Brands): Owner of UGG and other comfort/lifestyle footwear brands under Deckers (NYSE: DECK). Comparable premium-casual positioning, strong cultural cachet, multi-channel DTC + wholesale model, and recent success with brand elevation and full-price discipline — a useful analog for Dr. Martens' consumer-first pivot.
Emerging players
- Allbirds: Sustainable footwear brand (NASDAQ: BIRD) targeting Gen Z and sustainability-conscious consumers with recycled/plant-based materials. Comparable on the sustainability narrative (ReWair, Gen Phoenix) and overlapping demographic focus, though competing in casual/lifestyle rather than heritage boot categories.
- On Holding: Swiss premium athletic/lifestyle footwear brand (NYSE: ONON) that has rapidly gained cultural cachet with Gen Z and overlapping consumer segments. Not a direct competitor but a comparable peer in DTC-led premium footwear growth and brand-desire storytelling.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat4 records
Key risks6 records
Key highlights7 records
Customer concentration
Dr Martens social profiles
Digital presenceDr Martens financial estimates
Financial estimateRevenue estimate
Valuation estimate
Dr Martens leadership team
Management profileNumber of profiles
Profiles5 records
Dr Martens funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Dr Martens M&A and investment
M&A and investmentM&A
Investments1 record
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Dr Martens
What does Dr Martens do?
Dr. Martens designs, manufactures, and sells iconic heritage footwear including the 1460 boot, 1461 shoe, 2976 Chelsea boot, and platform styles (Jadon, Sinclair), along with sandals, loafers, Mary Janes, kids' footwear, bags, and accessories. The company sells through owned retail stores in major markets, 40+ country-specific e-commerce websites, and wholesale distribution to third-party retailers, complemented by the ReWair brand-owned resale platform for pre-loved products.
Is Dr Martens a public or private company?
Dr Martens is a public company. It is classified as public and is currently operating.
When was Dr Martens founded?
Dr Martens was founded in 1960. It employs 1,001 to 5,000 people.
Where is Dr Martens based?
Dr Martens is headquartered in Wollaston, United Kingdom, in the Europe region.
How does Dr Martens make money?
Three revenue lines are on record. Direct-to-Consumer (DTC) is the primary driver. The others are wholesale and brand-Owned Resale (ReWair).
Who are Dr Martens's main competitors?
Direct peers on record are Crocs, Clarks, Steve Madden, Hunter Boot, Birkenstock, Blundstone, Timberland and UGG (Deckers Brands). Emerging players are Allbirds and On Holding.
Does Dr Martens have an API?
No public API is recorded for Dr Martens.
What industry is Dr Martens in?
Dr Martens's product category is Heritage Footwear. Its primary akta.pro industry code is CRAAACAB, Casual & Lifestyle Footwear, with a secondary code of CRAAACAH, Sustainable & Eco-Friendly Footwear. Its NAICS code is 3162 and its SIC code is 3140.